Advent to sell generic drugmaker Zentiva to GTCR
Advent acquired Zentiva from Sanofi in 2018 and transformed the company into a highly successful standalone business
Advent acquired Zentiva from Sanofi in 2018 and transformed the company into a highly successful standalone business
The positive benefit-risk profile of vericiguat in its approved indication in patients with HFrEF following a recent heart failure event based on the pivotal Phase III VICTORIA trial remains unchanged
Merck will share two oral presentations on ASCVD treatment patterns and patient burden
Upgrades 2025 full-year CDMO sales and margin outlook
This collaboration ensures that patients receive comprehensive care, including emotional and psychological support throughout their fertility journey
Nadda noted that on the basis of economic caste census, 50 crore people were brought under this scheme
The acquisition of MDxK further strengthens the Business Unit’s position in the molecular diagnostics market
Subscribe To Our Newsletter & Stay Updated